Reports and Filings

MetaBlok and MetaMx Scientists

Lead scientists for MetaBlok™ and MetaMx™

AB569 Principal Scientist

Lead scientist for AB569 which targets Respiratory Pseudomonas Infections

BORG Peptide Solid Surface Interface Scientists

Lead scientists for BORG Peptides

Treatments for Inflammation Scientists

Lead scientists for Treatments for Inflammation

Recent News

July 14th 2020

Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.

June 30th 2020

Arch Biopartners Closes Non-Brokered Private Placement

Arch Biopartners

Contact us

+1 647 428 7031
info@archbiopartners.com
Mailing Address
27 St. Clair Ave East
P.O. Box 305
Toronto, Ontario
Canada M4T 2M5

Copyright Arch BioPartners 2020. All Rights Reserved. Legal notices.

PAGE TOP | TYPE SIZE | | RESET

Reports and Filings